Alerts will be sent to your verified email
Verify Email
LYKALABS
|
Lyka Labs
|
Trident Lifeline
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
62.44 % | 35.94 % | -23.88 % |
|
5yr average Equity Multiplier
|
2.9 | 1.91 | 1.78 |
|
5yr Average Asset Turnover Ratio
|
0.73 | 0.9 | 0.6 |
|
5yr Avg Net Profit Margin
|
-0.79 % | 17.11 % | -23.79 % |
|
Price to Book
|
3.82 | 6.05 | 4.74 |
|
P/E
|
52.73 | 29.6 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
32.55 Days | 94.4 Days | -10.34 Days |
|
Inventory Days
|
24.2 Days | 68.55 Days | 93.5 Days |
|
Days Receivable
|
92.33 Days | 104.41 Days | 66.75 Days |
|
Days Payable
|
106.74 Days | 126.58 Days | 179.8 Days |
|
5yr Average Interest Coverage Ratio
|
2.2 | 17.94 | -11.84 |
|
5yr Avg ROCE
|
25.83 % | 29.15 % | -15.03 % |
|
5yr Avg Operating Profit Margin
|
24.02 % | 16.89 % | -13.23 % |
|
5 yr average Debt to Equity
|
1.25 | 0.34 | 0.21 |
|
5yr CAGR Net Profit
|
n/a | 9.93 % | 0.22 % |
|
5yr Average Return on Assets
|
1.72 % | 15.87 % | -14.62 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
58.16 % | 63.04 % | 52.62 % |
|
Share Pledged by Promoters
|
0.0 | 3.46 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
10.36 % | -6.53 % | -13.79 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-3.53 % | 0.0 | 9.9 % |
|
Lyka Labs
|
Trident Lifeline
|
Brooks Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|